Home > > > > Report Detail

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Publisher Name :
Date: 10-Jan-2024
No. of pages: 87
Inquire Before Buying

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.

North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.

Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.

The major global manufacturers of Histone Deacetylase (HDAC) Inhibitors include 4SC, Acetylon Pharmaceuticals, Celleron Therapeutics, Chipscreen Biosciences, Chroma Therapeutics, CrystalGenomics, Curis, MEI Pharma and Mirati Therapeutics, etc. In 2023, The world's top three vendors accounted for approximately % of The revenue.

This report aims to provide a comprehensive presentation of The global market for Histone Deacetylase (HDAC) Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess The market competitive situation, analyze their position in The current marketplace, and make informed business decisions regarding Histone Deacetylase (HDAC) Inhibitors.

Report Scope

The Histone Deacetylase (HDAC) Inhibitors market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as The base year, with history and forecast data for The period from 2019 to 2030. This report segments The global Histone Deacetylase (HDAC) Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of The market, The report provides profiles of The competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help The Histone Deacetylase (HDAC) Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on The revenues, sales volume, and average price for The overall market and The sub-segments across The different segments, By Company, by Type, by Application, and By Regions.

Market Segmentation

By Company

- 4SC

- Acetylon Pharmaceuticals

- Celleron Therapeutics

- Chipscreen Biosciences

- Chroma Therapeutics

- CrystalGenomics

- Curis

- MEI Pharma

- Mirati Therapeutics

- Novartis

- Onxeo

- Repligen

- TetraLogic

Segment by Type

- Fatty Acid

- Hydroxamate

- Cyclic Peptide

- Benzamide

Segment by Application

- Treatment of Malignant Tumors

- Chronic Disease Treatment

- Others

Consumption By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Chapter Outline

Chapter 1: Introduces The Report Scope of The report, executive summary of different market segments (

By Region, by Type, by Application, etc), including The market size of each market segment, future development potential, and so on. It offers a high-level view of The current state of The market and its likely evolution in The short to mid-term, and long term.

Chapter 2: Detailed analysis of Histone Deacetylase (HDAC) Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Histone Deacetylase (HDAC) Inhibitors in regional level and country level. It provides a quantitative analysis of The market size and development potential of each region and its main countries and introduces The market development, future development prospects, market space, and market size of each country in The world.

Chapter 4: Provides The analysis of various market segments by Type, covering The market size and development potential of each market segment, to help readers find The blue ocean market in different market segments.

Chapter 5: Provides The analysis of various market segments by Application, covering The market size and development potential of each market segment, to help readers find The blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing The basic situation of The main companies in The market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including The upstream and downstream of The industry.

Chapter 8: Introduces The market dynamics, latest developments of The market, The driving factors and restrictive factors of The market, The challenges and risks faced by manufacturers in The industry, and The analysis of relevant policies in The industry.

Chapter 9: The main points and conclusions of The report.

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Table of Contents
1 Histone Deacetylase (HDAC) Inhibitors Market Overview
1.1 Product Overview and Scope of Histone Deacetylase (HDAC) Inhibitors
1.2 Histone Deacetylase (HDAC) Inhibitors Segment by Type
1.2.1 Global Histone Deacetylase (HDAC) Inhibitors Market Value Comparison by Type (2024-2030)
1.2.2 Fatty Acid
1.2.3 Hydroxamate
1.2.4 Cyclic Peptide
1.2.5 Benzamide
1.3 Histone Deacetylase (HDAC) Inhibitors Segment by Application
1.3.1 Global Histone Deacetylase (HDAC) Inhibitors Market Value by Application: (2024-2030)
1.3.2 Treatment of Malignant Tumors
1.3.3 Chronic Disease Treatment
1.3.4 Others
1.4 Global Histone Deacetylase (HDAC) Inhibitors Market Size Estimates and Forecasts
1.4.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue 2019-2030
1.4.2 Global Histone Deacetylase (HDAC) Inhibitors Sales 2019-2030
1.4.3 Global Histone Deacetylase (HDAC) Inhibitors Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Histone Deacetylase (HDAC) Inhibitors Market Competition by Manufacturers
2.1 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Manufacturers (2019-2024)
2.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Histone Deacetylase (HDAC) Inhibitors Average Price by Manufacturers (2019-2024)
2.4 Global Histone Deacetylase (HDAC) Inhibitors Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Histone Deacetylase (HDAC) Inhibitors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Histone Deacetylase (HDAC) Inhibitors, Product Type & Application
2.7 Histone Deacetylase (HDAC) Inhibitors Market Competitive Situation and Trends
2.7.1 Histone Deacetylase (HDAC) Inhibitors Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Histone Deacetylase (HDAC) Inhibitors Players Market Share by Revenue
2.7.3 Global Histone Deacetylase (HDAC) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Histone Deacetylase (HDAC) Inhibitors Retrospective Market Scenario by Region
3.1 Global Histone Deacetylase (HDAC) Inhibitors Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Histone Deacetylase (HDAC) Inhibitors Global Histone Deacetylase (HDAC) Inhibitors Sales by Region: 2019-2030
3.2.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Region: 2019-2024
3.2.2 Global Histone Deacetylase (HDAC) Inhibitors Sales by Region: 2025-2030
3.3 Global Histone Deacetylase (HDAC) Inhibitors Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region: 2019-2030
3.3.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region: 2019-2024
3.3.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region: 2025-2030
3.4 North America Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
3.4.1 North America Histone Deacetylase (HDAC) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2019-2030)
3.4.3 North America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
3.5.1 Europe Histone Deacetylase (HDAC) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2019-2030)
3.5.3 Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
3.6.1 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Country (2019-2030)
3.6.3 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
3.7.1 Latin America Histone Deacetylase (HDAC) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2019-2030)
3.7.3 Latin America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
3.8.1 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales by Country (2019-2030)
3.8.3 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2019-2030)
4.1.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2019-2024)
4.1.2 Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2025-2030)
4.1.3 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2019-2030)
4.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2019-2030)
4.2.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2019-2024)
4.2.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2025-2030)
4.2.3 Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Type (2019-2030)
4.3 Global Histone Deacetylase (HDAC) Inhibitors Price by Type (2019-2030)
5 Segment by Application
5.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2019-2030)
5.1.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2019-2024)
5.1.2 Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2025-2030)
5.1.3 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2019-2030)
5.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2019-2030)
5.2.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2019-2024)
5.2.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2025-2030)
5.2.3 Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Application (2019-2030)
5.3 Global Histone Deacetylase (HDAC) Inhibitors Price by Application (2019-2030)
6 Key Companies Profiled
6.1 4SC
6.1.1 4SC Corporation Information
6.1.2 4SC Description and Business Overview
6.1.3 4SC Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.1.4 4SC Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.1.5 4SC Recent Developments/Updates
6.2 Acetylon Pharmaceuticals
6.2.1 Acetylon Pharmaceuticals Corporation Information
6.2.2 Acetylon Pharmaceuticals Description and Business Overview
6.2.3 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.2.5 Acetylon Pharmaceuticals Recent Developments/Updates
6.3 Celleron Therapeutics
6.3.1 Celleron Therapeutics Corporation Information
6.3.2 Celleron Therapeutics Description and Business Overview
6.3.3 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.3.5 Celleron Therapeutics Recent Developments/Updates
6.4 Chipscreen Biosciences
6.4.1 Chipscreen Biosciences Corporation Information
6.4.2 Chipscreen Biosciences Description and Business Overview
6.4.3 Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.4.5 Chipscreen Biosciences Recent Developments/Updates
6.5 Chroma Therapeutics
6.5.1 Chroma Therapeutics Corporation Information
6.5.2 Chroma Therapeutics Description and Business Overview
6.5.3 Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.5.5 Chroma Therapeutics Recent Developments/Updates
6.6 CrystalGenomics
6.6.1 CrystalGenomics Corporation Information
6.6.2 CrystalGenomics Description and Business Overview
6.6.3 CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.6.4 CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.6.5 CrystalGenomics Recent Developments/Updates
6.7 Curis
6.6.1 Curis Corporation Information
6.6.2 Curis Description and Business Overview
6.6.3 Curis Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Curis Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.7.5 Curis Recent Developments/Updates
6.8 MEI Pharma
6.8.1 MEI Pharma Corporation Information
6.8.2 MEI Pharma Description and Business Overview
6.8.3 MEI Pharma Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.8.4 MEI Pharma Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.8.5 MEI Pharma Recent Developments/Updates
6.9 Mirati Therapeutics
6.9.1 Mirati Therapeutics Corporation Information
6.9.2 Mirati Therapeutics Description and Business Overview
6.9.3 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.9.5 Mirati Therapeutics Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Novartis Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Onxeo
6.11.1 Onxeo Corporation Information
6.11.2 Onxeo Histone Deacetylase (HDAC) Inhibitors Description and Business Overview
6.11.3 Onxeo Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Onxeo Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.11.5 Onxeo Recent Developments/Updates
6.12 Repligen
6.12.1 Repligen Corporation Information
6.12.2 Repligen Histone Deacetylase (HDAC) Inhibitors Description and Business Overview
6.12.3 Repligen Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Repligen Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.12.5 Repligen Recent Developments/Updates
6.13 TetraLogic
6.13.1 TetraLogic Corporation Information
6.13.2 TetraLogic Histone Deacetylase (HDAC) Inhibitors Description and Business Overview
6.13.3 TetraLogic Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.13.4 TetraLogic Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.13.5 TetraLogic Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Histone Deacetylase (HDAC) Inhibitors Industry Chain Analysis
7.2 Histone Deacetylase (HDAC) Inhibitors Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Histone Deacetylase (HDAC) Inhibitors Production Mode & Process
7.4 Histone Deacetylase (HDAC) Inhibitors Sales and Marketing
7.4.1 Histone Deacetylase (HDAC) Inhibitors Sales Channels
7.4.2 Histone Deacetylase (HDAC) Inhibitors Distributors
7.5 Histone Deacetylase (HDAC) Inhibitors Customers
8 Histone Deacetylase (HDAC) Inhibitors Market Dynamics
8.1 Histone Deacetylase (HDAC) Inhibitors Industry Trends
8.2 Histone Deacetylase (HDAC) Inhibitors Market Drivers
8.3 Histone Deacetylase (HDAC) Inhibitors Market Challenges
8.4 Histone Deacetylase (HDAC) Inhibitors Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Histone Deacetylase (HDAC) Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Histone Deacetylase (HDAC) Inhibitors Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Histone Deacetylase (HDAC) Inhibitors Market Competitive Situation by Manufacturers in 2023
Table 4. Global Histone Deacetylase (HDAC) Inhibitors Sales (MT) of Key Manufacturers (2019-2024)
Table 5. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Histone Deacetylase (HDAC) Inhibitors Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Histone Deacetylase (HDAC) Inhibitors Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Histone Deacetylase (HDAC) Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Histone Deacetylase (HDAC) Inhibitors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Histone Deacetylase (HDAC) Inhibitors, Product Type & Application
Table 12. Global Key Manufacturers of Histone Deacetylase (HDAC) Inhibitors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Histone Deacetylase (HDAC) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Histone Deacetylase (HDAC) Inhibitors as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Histone Deacetylase (HDAC) Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Histone Deacetylase (HDAC) Inhibitors Sales by Region (2019-2024) & (MT)
Table 18. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region (2019-2024)
Table 19. Global Histone Deacetylase (HDAC) Inhibitors Sales by Region (2025-2030) & (MT)
Table 20. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region (2025-2030)
Table 21. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region (2019-2024)
Table 23. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region (2025-2030)
Table 25. North America Histone Deacetylase (HDAC) Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2019-2024) & (MT)
Table 27. North America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2025-2030) & (MT)
Table 28. North America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2019-2024) & (MT)
Table 32. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2025-2030) & (MT)
Table 33. Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Region (2019-2024) & (MT)
Table 37. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Region (2025-2030) & (MT)
Table 38. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Histone Deacetylase (HDAC) Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2019-2024) & (MT)
Table 42. Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2025-2030) & (MT)
Table 43. Latin America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Sales by Country (2019-2024) & (MT)
Table 47. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Sales by Country (2025-2030) & (MT)
Table 48. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Histone Deacetylase (HDAC) Inhibitors Sales (MT) by Type (2019-2024)
Table 51. Global Histone Deacetylase (HDAC) Inhibitors Sales (MT) by Type (2025-2030)
Table 52. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2019-2024)
Table 53. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2025-2030)
Table 54. Global Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Type (2019-2024)
Table 57. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Type (2025-2030)
Table 58. Global Histone Deacetylase (HDAC) Inhibitors Price (USD/MT) by Type (2019-2024)
Table 59. Global Histone Deacetylase (HDAC) Inhibitors Price (USD/MT) by Type (2025-2030)
Table 60. Global Histone Deacetylase (HDAC) Inhibitors Sales (MT) by Application (2019-2024)
Table 61. Global Histone Deacetylase (HDAC) Inhibitors Sales (MT) by Application (2025-2030)
Table 62. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2019-2024)
Table 63. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2025-2030)
Table 64. Global Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Application (2019-2024)
Table 67. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Application (2025-2030)
Table 68. Global Histone Deacetylase (HDAC) Inhibitors Price (USD/MT) by Application (2019-2024)
Table 69. Global Histone Deacetylase (HDAC) Inhibitors Price (USD/MT) by Application (2025-2030)
Table 70. 4SC Corporation Information
Table 71. 4SC Description and Business Overview
Table 72. 4SC Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 73. 4SC Histone Deacetylase (HDAC) Inhibitors Product
Table 74. 4SC Recent Developments/Updates
Table 75. Acetylon Pharmaceuticals Corporation Information
Table 76. Acetylon Pharmaceuticals Description and Business Overview
Table 77. Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 78. Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Product
Table 79. Acetylon Pharmaceuticals Recent Developments/Updates
Table 80. Celleron Therapeutics Corporation Information
Table 81. Celleron Therapeutics Description and Business Overview
Table 82. Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 83. Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Product
Table 84. Celleron Therapeutics Recent Developments/Updates
Table 85. Chipscreen Biosciences Corporation Information
Table 86. Chipscreen Biosciences Description and Business Overview
Table 87. Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 88. Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Product
Table 89. Chipscreen Biosciences Recent Developments/Updates
Table 90. Chroma Therapeutics Corporation Information
Table 91. Chroma Therapeutics Description and Business Overview
Table 92. Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 93. Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Product
Table 94. Chroma Therapeutics Recent Developments/Updates
Table 95. CrystalGenomics Corporation Information
Table 96. CrystalGenomics Description and Business Overview
Table 97. CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 98. CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Product
Table 99. CrystalGenomics Recent Developments/Updates
Table 100. Curis Corporation Information
Table 101. Curis Description and Business Overview
Table 102. Curis Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 103. Curis Histone Deacetylase (HDAC) Inhibitors Product
Table 104. Curis Recent Developments/Updates
Table 105. MEI Pharma Corporation Information
Table 106. MEI Pharma Description and Business Overview
Table 107. MEI Pharma Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 108. MEI Pharma Histone Deacetylase (HDAC) Inhibitors Product
Table 109. MEI Pharma Recent Developments/Updates
Table 110. Mirati Therapeutics Corporation Information
Table 111. Mirati Therapeutics Description and Business Overview
Table 112. Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 113. Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Product
Table 114. Mirati Therapeutics Recent Developments/Updates
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 118. Novartis Histone Deacetylase (HDAC) Inhibitors Product
Table 119. Novartis Recent Developments/Updates
Table 120. Onxeo Corporation Information
Table 121. Onxeo Description and Business Overview
Table 122. Onxeo Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 123. Onxeo Histone Deacetylase (HDAC) Inhibitors Product
Table 124. Onxeo Recent Developments/Updates
Table 125. Repligen Corporation Information
Table 126. Repligen Description and Business Overview
Table 127. Repligen Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 128. Repligen Histone Deacetylase (HDAC) Inhibitors Product
Table 129. Repligen Recent Developments/Updates
Table 130. TetraLogic Corporation Information
Table 131. TetraLogic Description and Business Overview
Table 132. TetraLogic Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 133. TetraLogic Histone Deacetylase (HDAC) Inhibitors Product
Table 134. TetraLogic Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Histone Deacetylase (HDAC) Inhibitors Distributors List
Table 138. Histone Deacetylase (HDAC) Inhibitors Customers List
Table 139. Histone Deacetylase (HDAC) Inhibitors Market Trends
Table 140. Histone Deacetylase (HDAC) Inhibitors Market Drivers
Table 141. Histone Deacetylase (HDAC) Inhibitors Market Challenges
Table 142. Histone Deacetylase (HDAC) Inhibitors Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Histone Deacetylase (HDAC) Inhibitors
Figure 2. Global Histone Deacetylase (HDAC) Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Histone Deacetylase (HDAC) Inhibitors Market Share by Type in 2023 & 2030
Figure 4. Fatty Acid Product Picture
Figure 5. Hydroxamate Product Picture
Figure 6. Cyclic Peptide Product Picture
Figure 7. Benzamide Product Picture
Figure 8. Global Histone Deacetylase (HDAC) Inhibitors Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Histone Deacetylase (HDAC) Inhibitors Market Share by Application in 2023 & 2030
Figure 10. Treatment of Malignant Tumors
Figure 11. Chronic Disease Treatment
Figure 12. Others
Figure 13. Global Histone Deacetylase (HDAC) Inhibitors Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Histone Deacetylase (HDAC) Inhibitors Market Size (2019-2030) & (US$ Million)
Figure 15. Global Histone Deacetylase (HDAC) Inhibitors Sales (2019-2030) & (MT)
Figure 16. Global Histone Deacetylase (HDAC) Inhibitors Average Price (USD/MT) & (2019-2030)
Figure 17. Histone Deacetylase (HDAC) Inhibitors Report Years Considered
Figure 18. Histone Deacetylase (HDAC) Inhibitors Sales Share by Manufacturers in 2023
Figure 19. Global Histone Deacetylase (HDAC) Inhibitors Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Histone Deacetylase (HDAC) Inhibitors Players: Market Share by Revenue in 2023
Figure 21. Histone Deacetylase (HDAC) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Histone Deacetylase (HDAC) Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2019-2030)
Figure 24. North America Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2019-2030)
Figure 28. Europe Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2019-2030)
Figure 29. Germany Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region (2019-2030)
Figure 36. China Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2019-2030)
Figure 47. Latin America Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Histone Deacetylase (HDAC) Inhibitors by Type (2019-2030)
Figure 57. Global Revenue Market Share of Histone Deacetylase (HDAC) Inhibitors by Type (2019-2030)
Figure 58. Global Hist
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs